Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues

  • Authors:
    • Junichi Kurebayashi
    • Yutaka Yamamoto
    • Kiyoshi Udagawa
    • Sumiko Okubo
    • Masakazu Fukushima
    • Hiroshi Sonoo
  • View Affiliations

  • Published online on: May 1, 2004     https://doi.org/10.3892/or.11.5.973
  • Pages: 973-979
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Thymidilate synthase (TS) is a major target of 5-fluorouracil (5-FU) and dihydropyrimidine dehydrogenase (DPD) is a rate-limiting enzyme in the degradation of 5-FU. Intratumoral activity and expression levels of both enzymes are suggested to be predictive markers for response to 5-FU-based chemotherapy in cancer patients. Several different methods are used to measure intratumoral levels of TS and DPD. We developed new enzyme-linked immunosorbent assays (ELISAs) for these enzymes. New ELISAs were produced using anti-TS and anti-DPD polyclonal antibodies obtained using recombinant human TS and purified DPD from pig liver, respectively. Intra-assay coefficients of variations (CVs) were less than 5% in both ELISAs. Inter-assay CVs tested using the extract from 20 breast cancer specimens were 1.5-24.2% for TS-ELISA and 0.4-7.2% for DPD. Importantly, TS and DPD levels measured by the respective ELISAs closely related to TS activity (r2=0.8492) and DPD activity (r2=0.7666), respectively, measured by the respective substrate assays. To investigate the correlations between clinicopathological characteristics and intratumoral TS and DPD levels, data on 52 breast cancer patients were analyzed. Estrogen receptor (ER)-negative tumors had significantly higher TS and DPD levels than ER-positive tumors. Progesterone receptor (PgR)-negative tumors showed a significantly higher DPD level than PgR-positive tumors. There was no significant correlation of the TS or DPD levels with other clinicopathological factors in this preliminary study. Further studies are warranted to investigate predictive and prognostic values of intratumoral TS and DPD levels in various malignancies using these ELISAs.

Related Articles

Journal Cover

May 2004
Volume 11 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kurebayashi J, Yamamoto Y, Udagawa K, Okubo S, Fukushima M and Sonoo H: Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues. Oncol Rep 11: 973-979, 2004
APA
Kurebayashi, J., Yamamoto, Y., Udagawa, K., Okubo, S., Fukushima, M., & Sonoo, H. (2004). Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues. Oncology Reports, 11, 973-979. https://doi.org/10.3892/or.11.5.973
MLA
Kurebayashi, J., Yamamoto, Y., Udagawa, K., Okubo, S., Fukushima, M., Sonoo, H."Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues". Oncology Reports 11.5 (2004): 973-979.
Chicago
Kurebayashi, J., Yamamoto, Y., Udagawa, K., Okubo, S., Fukushima, M., Sonoo, H."Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues". Oncology Reports 11, no. 5 (2004): 973-979. https://doi.org/10.3892/or.11.5.973